Alphabet, Amazon, and Microsoft lead the tech reports, with Exxon, 3M, Ford, and many more also on tap. Plus, the first reading of first-quarter GDP.
Intermediate-term bonds are gaining assets despite a rising interest-rate environment as investors continue to seek diversification and income.
First-quarter earnings for the healthcare firm reinforce that it is not the best buy. Plus, slow growth for IBM, and Netflix is overvalued.
March data confirms 2017 started off with a whimper, and it will be hard to make up that ground in the rest of the year.
Vanguard Small Cap Value ETF uses an approach that promotes low turnover and diversifies risk.
With margin compression coming, we think the market may unfairly punish the wide-moat truck brokerage leader creating an opportunity for investors.
Experienced managers and a solid process allow AB High Income to navigate the riskier sectors of the bond market.
After some recent changes, the SSA's Andrew Salata clarifies who can take what benefits when.
We think Allergan is well positioned with a strong pipeline of specialty drugs and attractively undervalued today.
The market is overlooking the immense growth potential in Cenovus' reserves that can be brought on line with new, cost-lowering technology.
We'll get updates from Bank of America, Goldman Sachs, Morgan Stanley, Netflix, Visa, GE, and more.
The market's overall valuation remains near its 52-week high, with basic materials being the priciest sector and real estate offering the most value.
©2017 Morningstar Advisor. All right reserved.